Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].

Authors :: Harman-Boehm I
Source :: The Israel Medical Association journal : IMAJ [Isr Med Assoc J] 2004 May; Vol. 6 (5), pp. 296-8.
Publication Year :: 2004

Subjects :: Diabetic Nephropathies complications
Diabetic Nephropathies physiopathology
Humans
Hypertension complications
Proteinuria drug therapy
Randomized Controlled Trials as Topic
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors therapeutic use
Diabetic Nephropathies drug therapy

Tools